Heart Beat October 2009 Issue

Heart Beat: October 2009

Tight control of systolic blood pressure reduces the risk of developing left ventricular hypertrophy (LVH) compared to the more common, slightly higher systolic blood pressure control. In a study published in the Aug. 15 issue of the Lancet, researchers found that lowering systolic (the top number) to 130 mm Hg instead of the more common target of 140 mm Hg reduced the risk of electrocardiographic LVH by 37 percent. The risk of heart attack, stroke, angina and other clinical events was also noticeably lower in the group of study subjects whose blood pressure was brought below 130. LVH is a thickening of the heart muscle around the left ventricle and can be a marker for several forms of heart disease. LVH can also be reversed, usually due to lowering blood pressure. Researchers warned that lowering systolic pressure below 130, and formally altering existing guidelines, requires more research, and your particular target blood pressure levels should be discussed thoroughly with your doctor.

To continue reading this article you must be a paid subscriber.

Subscribe to Heart Advisor

Get the next year of HEART ADVISOR for just $20. That's a savings of $19 off the regular rate.

With your paid subscription you will receive unlimited access to all of our online content. That is over a decade of previous issues from Cleveland Clinic, the hospital rated #1 in cardiac care by U.S. News & World Report - free of charge.

Subscriber Log In

Forgot your password? Click Here.

Already subscribe but haven't registered for all the benefits of the website? Click here.